NCT02226458View on ClinicalTrials.gov

An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

January 31, 2016

Conditions
Autism Spectrum Disorder
Interventions
DRUG

EPI-743

Sponsors
All Listed Sponsors
lead

Edison Pharmaceuticals Inc

INDUSTRY